About Neurolens
Neurolens is a company based in Coppell (United States) founded in 2008 by Davis Corley.. Neurolens has raised $126.19 million across 9 funding rounds from investors including Marshall Wace, Trinity Cap and MVM Partners. Neurolens offers products and services including Neurolenses and Neurolens Test. Neurolens operates in a competitive market with competitors including Laclarée, Azalea Vision, SynergEyes, Nexis Vision and ABH Optics, among others.
- Headquarter Coppell, United States
- Founders Davis Corley
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$126.19 M (USD)
in 9 rounds
-
Latest Funding Round
$45 M (USD), Debt – Conventional
Dec 06, 2023
-
Investors
Marshall Wace
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurolens
Neurolens offers a comprehensive portfolio of products and services, including Neurolenses and Neurolens Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Lenses that correct eye misalignment to alleviate symptoms.
Questionnaire and measurement for identifying eye misalignment.
Funding Insights of Neurolens
Neurolens has successfully raised a total of $126.19M across 9 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $45 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Debt – Conventional — $45.0M
-
First Round
First Round
(20 Oct 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Debt – Conventional - Neurolens | Valuation |
investors |
|
| Sep, 2022 | Amount | Series C - Neurolens | Valuation | MVM | |
| Mar, 2020 | Amount | Series B - Neurolens | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neurolens
Neurolens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Marshall Wace, Trinity Cap and MVM Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Founded Year | Domain | Location | |
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location | |
|
Long-short equity strategies are managed through specialized hedge funds.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neurolens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neurolens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurolens Comparisons
Competitors of Neurolens
Neurolens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laclarée, Azalea Vision, SynergEyes, Nexis Vision and ABH Optics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Eye-wear solutions for presbyopia correction are developed using liquid refraction.
|
|
| domain | founded_year | HQ Location |
Developer of technology for people with high light sensitivity and ocular disorders
|
|
| domain | founded_year | HQ Location |
Hybrid contact lense manufacturers
|
|
| domain | founded_year | HQ Location |
Ocular lens and surface technologies for ophthalmic devices are developed.
|
|
| domain | founded_year | HQ Location |
Developer of lightweight eyeglass lenses
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurolens
Frequently Asked Questions about Neurolens
When was Neurolens founded?
Neurolens was founded in 2008 and raised its 1st funding round 6 years after it was founded.
Where is Neurolens located?
Neurolens is headquartered in Coppell, United States. It is registered at Coppell, Texas, United States.
Who is the current CEO of Neurolens?
Davis Corley is the current CEO of Neurolens. They have also founded this company.
Is Neurolens a funded company?
Neurolens is a funded company, having raised a total of $126.19M across 9 funding rounds to date. The company's 1st funding round was a Series B of $23.82M, raised on Oct 20, 2014.
What does Neurolens do?
Provider of prescription lenses and solution for problems related to Digital Vision Syndrome. The company has a patented Contoured Prism technology and is the first and only prescription lenses to provide comfort for the majority of adults who complain of headaches, neckshoulder pain, and eyestrain when using digital devices, reading, or doing detail work, the daily symptoms of Digital Vision Syndrome, DVS. With this technology, the company corrects eye misalignment naturally and provides comfortable vision.
Who are the top competitors of Neurolens?
Neurolens's top competitors include Azalea Vision, Laclarée and SynergEyes.
What products or services does Neurolens offer?
Neurolens offers Neurolenses and Neurolens Test.
Who are Neurolens's investors?
Neurolens has 5 investors. Key investors include Marshall Wace, Trinity Cap, MVM Partners, Falcon-Vision, and Bluestem.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.